vs
Pediatrix Medical Group, Inc.（MD）とOSI SYSTEMS INC（OSIS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $464.1M、OSI SYSTEMS INCの約1.1倍）。OSI SYSTEMS INCの純利益率が高く（8.3% vs 6.8%、差は1.5%）。OSI SYSTEMS INCの前年同期比売上増加率が高い（10.5% vs -1.7%）。過去8四半期でOSI SYSTEMS INCの売上複合成長率が高い（7.0% vs -0.1%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
OSIシステムズ社は米国カリフォルニア州に本社を置く企業で、空港保安用X線検査装置・金属探知機などのセキュリティ検査システム、医療用モニタリング・麻酔システム、光電子デバイスの開発・販売を手がけ、子会社にSpacelabs Healthcare、Rapiscan Systems、OSI Optoelectronicsがあり、全世界で約3180人の従業員を擁する。
MD vs OSIS — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $464.1M |
| 純利益 | $33.7M | $38.7M |
| 粗利率 | — | 32.7% |
| 営業利益率 | 9.9% | 12.7% |
| 純利益率 | 6.8% | 8.3% |
| 売上前年比 | -1.7% | 10.5% |
| 純利益前年比 | 10.5% | 2.3% |
| EPS（希薄化後） | $0.40 | $2.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $464.1M | ||
| Q3 25 | $492.9M | $384.6M | ||
| Q2 25 | $468.8M | $505.0M | ||
| Q1 25 | $458.4M | $444.4M | ||
| Q4 24 | $502.4M | $419.8M | ||
| Q3 24 | $511.2M | $344.0M | ||
| Q2 24 | $504.3M | $480.9M | ||
| Q1 24 | $495.1M | $405.4M |
| Q4 25 | $33.7M | $38.7M | ||
| Q3 25 | $71.7M | $20.6M | ||
| Q2 25 | $39.3M | $52.7M | ||
| Q1 25 | $20.7M | $41.1M | ||
| Q4 24 | $30.5M | $37.8M | ||
| Q3 24 | $19.4M | $17.9M | ||
| Q2 24 | $-153.0M | $44.7M | ||
| Q1 24 | $4.0M | $34.0M |
| Q4 25 | — | 32.7% | ||
| Q3 25 | — | 32.0% | ||
| Q2 25 | — | 33.3% | ||
| Q1 25 | — | 33.8% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | — | 35.3% | ||
| Q2 24 | — | 32.1% | ||
| Q1 24 | — | 33.6% |
| Q4 25 | 9.9% | 12.7% | ||
| Q3 25 | 13.8% | 8.6% | ||
| Q2 25 | 12.8% | 14.5% | ||
| Q1 25 | 7.0% | 12.7% | ||
| Q4 24 | 7.8% | 13.8% | ||
| Q3 24 | 6.6% | 8.8% | ||
| Q2 24 | -31.3% | 13.1% | ||
| Q1 24 | 3.2% | 12.7% |
| Q4 25 | 6.8% | 8.3% | ||
| Q3 25 | 14.5% | 5.3% | ||
| Q2 25 | 8.4% | 10.4% | ||
| Q1 25 | 4.5% | 9.3% | ||
| Q4 24 | 6.1% | 9.0% | ||
| Q3 24 | 3.8% | 5.2% | ||
| Q2 24 | -30.3% | 9.3% | ||
| Q1 24 | 0.8% | 8.4% |
| Q4 25 | $0.40 | $2.22 | ||
| Q3 25 | $0.84 | $1.18 | ||
| Q2 25 | $0.46 | $3.04 | ||
| Q1 25 | $0.24 | $2.40 | ||
| Q4 24 | $0.37 | $2.22 | ||
| Q3 24 | $0.23 | $1.05 | ||
| Q2 24 | $-1.84 | $2.57 | ||
| Q1 24 | $0.05 | $1.95 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $336.7M |
| 総負債低いほど良い | $570.5M | $1.0B |
| 株主資本純資産 | $865.9M | $845.5M |
| 総資産 | $2.2B | $2.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | 1.19× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $336.7M | ||
| Q3 25 | $340.1M | $124.4M | ||
| Q2 25 | $224.7M | $106.4M | ||
| Q1 25 | $99.0M | $95.8M | ||
| Q4 24 | $229.9M | $101.6M | ||
| Q3 24 | $103.8M | $85.1M | ||
| Q2 24 | $19.4M | $95.4M | ||
| Q1 24 | $8.0M | $101.4M |
| Q4 25 | $570.5M | $1.0B | ||
| Q3 25 | $577.2M | $442.2M | ||
| Q2 25 | $583.9M | $471.6M | ||
| Q1 25 | $590.5M | $473.2M | ||
| Q4 24 | $597.1M | $474.8M | ||
| Q3 24 | — | $476.3M | ||
| Q2 24 | — | $137.6M | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $845.5M | ||
| Q3 25 | $890.7M | $946.0M | ||
| Q2 25 | $833.8M | $951.1M | ||
| Q1 25 | $789.2M | $879.3M | ||
| Q4 24 | $764.9M | $825.8M | ||
| Q3 24 | $732.5M | $786.5M | ||
| Q2 24 | $706.5M | $863.5M | ||
| Q1 24 | $856.2M | $813.4M |
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.2B | $2.3B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | $2.2B | $2.1B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $2.0B | $1.9B | ||
| Q1 24 | $2.2B | $1.8B |
| Q4 25 | 0.66× | 1.19× | ||
| Q3 25 | 0.65× | 0.47× | ||
| Q2 25 | 0.70× | 0.50× | ||
| Q1 25 | 0.75× | 0.54× | ||
| Q4 24 | 0.78× | 0.57× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $62.2M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $55.5M |
| FCFマージンFCF / 売上 | — | 12.0% |
| 設備投資強度設備投資 / 売上 | — | 1.4% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | 1.61× |
| 直近12ヶ月FCF直近4四半期 | — | $137.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $62.2M | ||
| Q3 25 | $137.3M | $17.1M | ||
| Q2 25 | $137.2M | $562.0K | ||
| Q1 25 | $-117.5M | $81.6M | ||
| Q4 24 | $133.0M | $52.5M | ||
| Q3 24 | $91.8M | $-37.2M | ||
| Q2 24 | $107.0M | $-29.0M | ||
| Q1 24 | $-125.2M | $-52.1M |
| Q4 25 | — | $55.5M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $47.1M | ||
| Q3 24 | — | $-44.9M | ||
| Q2 24 | — | $-37.5M | ||
| Q1 24 | — | $-57.0M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | -1.1% | ||
| Q1 25 | — | 17.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | -13.0% | ||
| Q2 24 | — | -7.8% | ||
| Q1 24 | — | -14.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | 3.39× | 1.61× | ||
| Q3 25 | 1.91× | 0.83× | ||
| Q2 25 | 3.49× | 0.01× | ||
| Q1 25 | -5.66× | 1.98× | ||
| Q4 24 | 4.36× | 1.39× | ||
| Q3 24 | 4.72× | -2.07× | ||
| Q2 24 | — | -0.65× | ||
| Q1 24 | -31.03× | -1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
OSIS
| Security Division | $334.7M | 72% |
| Optoelectronics And Manufacturing Division | $92.8M | 20% |
| Healthcare Division | $36.5M | 8% |
